NMPA Approval

Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets（Ⅰ）

Approval Number

国药准字H20254536

Company安徽贝克生物制药有限公司

Registration Date

June 10, 2025

Drug Information

Generic Name

依非米替片(Ⅰ)

Dosage Form

片剂

Strength

每片含依非韦伦0.4g，拉米夫定0.3g，富马酸替诺福韦二吡呋酯0.3g

Drug Type

化学药品

Registration Date

June 10, 2025

Company Information

Applicant Company

Company Name安徽贝克生物制药有限公司

Company Address

安徽省合肥市高新技术开发区红枫路30号

Manufacturing Company

Company Name安徽贝克生物制药有限公司

Company Address

合肥市高新技术开发区红枫路30号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

依非米替片(Ⅰ) - NMPA 批准文号 | MedPath